Blocking BRE expression in Leydig cells inhibits steroidogenesis by down-regulating 3beta-hydroxysteroid...

Area of Science:

• Endocrinology
• Molecular Biology
• Biochemistry

Background:

• Steroidogenesis involves multiple enzymes and proteins, including cholesterol side-chain cleavage enzyme (P450scc), 3beta-hydroxysteroid dehydrogenase/isomerase (3beta-HSD), and steroidogenic acute regulatory (StAR) protein.
• A novel protein, BRE, is found in the brain, adrenals, and gonads and shows high expression in hyperplastic rat adrenals with impaired steroidogenesis.

Purpose of the Study:

• To investigate the role of the novel protein BRE in steroidogenic tissues.
• To elucidate the mechanism by which BRE influences steroid hormone production.

Main Methods:

• Mouse Leydig tumor cells (mLTC-1) were transfected with BRE antisense probes.
• Assessed morphological changes, cAMP production, StAR and P450scc mRNA expression.
• Measured progesterone, testosterone, and pregnenolone yields.
• Evaluated the conversion of exogenous progesterone and pregnenolone.
• Quantified 3beta-HSD type I (3ss-HSDI) mRNA expression.

Main Results:

• BRE antisense cells showed large lipid droplets and failed to respond to human chorionic gonadotropin (hCG).
• Progesterone and testosterone yields decreased, while pregnenolone increased in response to hCG or 22(R)OH-cholesterol.
• Impaired conversion of pregnenolone to progesterone was observed, indicating a role for 3beta-HSD.
• Reduced 3beta-HSD type I mRNA expression was found in BRE antisense cells.

Conclusions:

• BRE influences steroidogenesis by affecting 3beta-HSD activity, likely impacting its transcription.
• This suggests BRE plays a regulatory role in the pregnenolone-to-progesterone conversion step.
• BRE's function is critical for efficient steroid hormone synthesis in Leydig cells.